Rizatriptan 5 mg Immediate Release Tablets is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Rizatriptan 5 mg Immediate Release Tablets
FDA Labeled Indications
Rizatriptan is FDA-labeled for the acute treatment of migraine with or without aura.
Contraindications
Contraindications include ischemic coronary artery disease, coronary vasospasm, history of stroke or transient ischemic attack, peripheral vascular disease, ischemic bowel disease, uncontrolled hypertension, hemiplegic or basilar migraine, recent use of another triptan or ergot-type drug, MAO-A inhibitor use, and hypersensitivity.
Warnings
Warnings include heart attack, coronary vasospasm, arrhythmias, chest or throat tightness, stroke, serotonin syndrome, increased blood pressure, medication overuse headache, and serious allergic reactions.
Precautions
Use only for diagnosed migraine. Use caution with cardiovascular risk factors, liver or kidney impairment, propranolol, serotonergic drugs, and frequency of use.
Adverse Reactions
Adverse reactions may include dizziness, sleepiness, fatigue, pain or pressure sensations, nausea, dry mouth, and tingling.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Ropinirole 0.25 mg Immediate Release Tablets, Risperidone 4 mg Tablets, Rosuvastatin 5 mg Tablets, and Risperidone 3 mg Tablets.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Rizatriptan 5 mg Immediate Release Tablets is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
